Conexeu director reports 50,000 stock options
Conexeu Sciences Inc. director Costa Andrew reported holding an option to buy common stock, covering 50,000 underlying shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Conexeu Sciences Inc. director Costa Andrew reported holding an option to buy common stock, covering 50,000 underlying shares. The option has an exercise price of $2.30 per share and expires on February 9, 2031.
According to a footnote, these options were granted on February 9, 2026 and vest over 12 months, with 25% vesting at three, six, nine and twelve months from the grant date.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Costa Andrew
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Option (right to buy) — 50,000 contracts (Direct)
Footnotes (1)
- F1. Represents options to purchase shares of common stock that were granted on February 9, 2026 and vest over a 12-month period (25% three, six, nine and twelve months from the date of grant).
Key Figures
Underlying shares: 50,000 shares
Exercise price: $2.30 per share
Options held after report: 50,000 options
+2 more
5 metrics
Underlying shares
50,000 shares
Underlying common stock for reported option holding
Exercise price
$2.30 per share
Option (right to buy) on Conexeu Sciences common stock
Options held after report
50,000 options
Total shares underlying options following reported holding
Expiration date
February 9, 2031
Option term for 50,000 underlying shares
Vesting schedule
25% at 3, 6, 9, 12 months
Twelve‑month vesting from February 9, 2026 grant date
Key Terms
Option (right to buy), Form 3, exercise price, expiration date, +1 more
5 terms
Option (right to buy) financial
"security_title: "Option (right to buy)""
Form 3 regulatory
"INSIDER FILING DATA (Form 3)"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
exercise price financial
"conversion_or_exercise_price: "2.3000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2031-02-09T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest over a 12-month period financial
"vest over a 12-month period (25% three, six, nine and twelve months"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Conexeu Sciences (CNXU) director Costa Andrew report on this Form 3?
Costa Andrew reports holding an option to buy Conexeu Sciences common stock, tied to 50,000 underlying shares at a $2.30 exercise price. The filing establishes his initial derivative holdings as a company insider.
What is the exercise price of the Conexeu Sciences (CNXU) option held by Costa Andrew?
The option held by Costa Andrew has an exercise price of $2.30 per share. This is the price at which he can purchase Conexeu Sciences common stock for the 50,000 underlying shares if and when the option is exercised.
When do Costa Andrew’s Conexeu Sciences (CNXU) options expire?
The options reported on the Form 3 expire on February 9, 2031. After that date, any unexercised portion will no longer be available, so the long-dated term provides several years of potential exercise window, subject to vesting.
How do the Conexeu Sciences (CNXU) options reported by Costa Andrew vest?
The options were granted on February 9, 2026 and vest over 12 months. Vesting occurs in four equal 25% installments at three, six, nine, and twelve months after the grant date, gradually increasing the exercisable portion of the award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates